Medication info

Baiduo Tablet 10/20mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
White to off-white, double convex rectangular tablets
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Expired

MFDS item code 201902087 · Approved 2019.04.05

This product's status changed to Expired on 2024.04.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of mixed dyslipidemia and primary and homozygous familial hypercholesterolemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg~10/40mg per day. The generally recommended initial dose is 10/20mg per day. For patients who require less reduction in LDL cholesterol, treatment may be started at 10/10mg per day. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg per day, administered once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 4. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. Use caution and monitor carefully when administering higher doses of this drug to these patients (see 4. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is required for elderly patients. Concomitant administration with other drugs (See 5. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of mixed dyslipidemia and primary and homozygous familial hypercholesterolemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated ApoB protein
  • elevated triglycerides
  • reduced HDL-cholesterol
  • atherosclerotic vascular diseases due to hypercholesterolemia
View approved original text

This medication helps reduce elevated total cholesterol, LDL-cholesterol, ApoB protein, and triglycerides in patients with primary hypercholesterolemia and mixed hyperlipidemia while increasing 'good' HDL-cholesterol. It is particularly used as an adjunct therapy for patients with homozygous familial hypercholesterolemia or when alternative therapies are not suitable. It is important to confirm the underlying causes of dyslipidemia influenced by other health conditions or medications and treat them, in conjunction with dietary therapy during treatment. This drug is used to effectively manage lipid levels to reduce the risk of cardiovascular diseases.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg~10/40mg per day. The generally recommended initial dose is 10/20mg per day. For patients who require less reduction in LDL cholesterol, treatment may be started at 10/10mg per day. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg per day, administered once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 4. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. Use caution and monitor carefully when administering higher doses of this drug to these patients (see 4. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is required for elderly patients. Concomitant administration with other drugs (See 5. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication may cause muscle-related side effects such as myopathy and rhabdomyolysis. Caution is especially required when taking high doses or using with certain medications, as the risk may increase. This medication should not be used in patients with hypersensitivity to its ingredients, severe liver dysfunction, or in pregnant or nursing women. It should be discontinued immediately if pregnancy is confirmed, as it may be harmful to the fetus. Patients with liver dysfunction should have regular liver function tests while using this medication, and it should be stopped immediately if liver damage is suspected. If muscle pain, weakness, or discomfort occurs during usage, consult a doctor immediately, and it may be necessary to discontinue the medication if these symptoms worsen or persist. This medication may interact with several other drugs, so inform healthcare providers if taking other medications, especially with CYP3A4 inhibitors, fibrates, or anticoagulants. Elderly patients or those with reduced kidney function may be more sensitive to side effects, requiring extra caution while using the medication. It is advisable to avoid grapefruit juice or excessive grapefruit consumption during treatment, and do not change or stop the dosage without consulting a healthcare provider. This medication may elevate blood sugar levels, so patients at risk for diabetes should monitor their blood sugar levels regularly. Safety and efficacy have not been adequately established in children and adolescents, so expert guidance is necessary when used. There is no specific antidote for overdose, so in suspected cases, seek immediate medical attention for appropriate treatment.

Side effects

myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, weakness, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, immune-mediated necrotizing myopathy, taste disorder, extraocular muscle dysfunction, facial partial paralysis, tremor, dizziness, sensory disturbance, peripheral neuropathy, peripheral nerve paralysis, psychiatric disorders, anxiety, sleep disorders, depression, cognitive impairment, interstitial lung disease, anaphylaxis, angioedema, lupus erythematosus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, thrombocytopenia, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, eosinophilia, arthritis, arthralgia, urticaria, photosensitivity, fever, chills, flushing, malaise, dyspnea, toxic epidermal necrolysis, mucocutaneous syndrome, pancreatitis, hepatitis, cholestatic jaundice, fatty liver changes, cirrhosis, fulminant hepatic necrosis, liver cancer, liver failure, decreased appetite, vomiting, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ocular muscle paralysis, anemia, elevated aminotransferases, elevated ALP, elevated gamma-GT, increased bilirubin levels, thyroid dysfunction, transient liver function test abnormalities, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial edema, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. It is best stored at room temperature, ideally between 1 and 30 degrees Celsius. This helps maintain the medication's efficacy and safety for a long time.

Appearance and packaging

Appearance

White to off-white, double convex rectangular tablets

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.